GlassScriptPhysician profile
Alexander Paraschos
NPI 1184641169
$3,511.51
in general payments reported to CMS, 2019-2025
19 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $13.15 · 2021: $271 · 2022: $254 · 2023: $144 · 2024: $1,013 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,627 · Travel and Lodging: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,626.98 |
| Travel and Lodging | $592.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,358.44 | 2021-2025 | Micra, Linq II, Selectsecure |
| Boston Scientific Corporation | $969.35 | 2019-2025 | Ingevity+, Lux-Dx Insertable Cardiac Monitor, Patientcare Link |
| Medtronic Vascular, INC. | $621.29 | 2019 | |
| Pfizer INC. | $174.93 | 2019-2025 | |
| Shockwave Medical, INC | $79.74 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acist Medical Systems, INC. | $64.87 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $53.08 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $50.52 | 2019-2022 | |
| Chiesi USA, INC. | $49.19 | 2021-2025 | Kengreal |
| Abiomed | $28.43 | 2023 | Impella |
| Sanofi-Aventis U.S. LLC | $18.10 | 2021 | |
| Irhythm Technologies, INC. | $13.83 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.10 | 2019 | |
| Abbott Laboratories | $11.55 | 2021 | |
| Cardiovascular Systems INC. | $5.09 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Paraschos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.